Agenus Inc.
€2.945
EUR
Last updated on --.
24h volume466.31K
24h highest3.0358 EUR
24h lowest2.8724 EUR
24h Price movement+3.16%
AGEN recent prices
24 Hours
+3.16%+€0.0903
30 days
-11.83%-€0.3956
60 days
+5.86%+€0.1634
90 days
+3.00%+€0.086
Key data
Previous close2.8552 EUR
Market cap112.81M EUR
Volume466.31K
P/E ratio2.040000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)1.3330 EUR
Net income (FY)53.74M EUR
Revenue (FY)106.52M EUR
Last report date11 May 2026
About Agenus Inc.
HeadquartersLEXINGTON
Employees (FY)81.00
Revenue per employee (FY)1.32M EUR
Net income per employee (FY)663.51K EUR
Listed onNasdaq
AGEN conversion tables
 |  |
|---|---|
| 0.5 AGEN | 1.472 EUR |
| 1 AGEN | 2.945 EUR |
| 5 AGEN | 14.72 EUR |
| 10 AGEN | 29.45 EUR |
| |
|---|---|
| 0.5 EUR | 0.16975 AGEN |
| 1 EUR | 0.3395 AGEN |
| 5 EUR | 1.697 AGEN |
| 10 EUR | 3.395 AGEN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
AGEN is trading at €2.945, +3.16% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AGEN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AGEN is currently trading at €2.945, +3.16% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AGEN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AGEN's P/E ratio is currently 2.040000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AGEN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AGEN's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Agenus Inc.'s market cap is currently 112.81M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume466.31K
24h highest3.0358 EUR
24h lowest2.8724 EUR
24h Price movement+3.16%
Start trade with AGEN Perpetual
Sign up to trade